Conceptio › Archive › HAL (France)
HAL (France)open access

Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics

N. Villain et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
alzheimerbiomarkerclinicalpracticeguidelines
0, Clinical practice, Biomarker, Alzheimer, Guidelines, Lecanemab
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 161197
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.